Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 81 | 2021 | 605 | 4.960 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 9 | 2021 | 119 | 1.780 |
Why?
|
Rats | 122 | 2021 | 1910 | 1.730 |
Why?
|
Rats, Inbred BB | 68 | 2021 | 134 | 1.610 |
Why?
|
Autoimmunity | 12 | 2021 | 223 | 1.460 |
Why?
|
Genetic Predisposition to Disease | 20 | 2019 | 676 | 1.210 |
Why?
|
Diabetes Mellitus, Experimental | 39 | 2021 | 190 | 1.190 |
Why?
|
Antibodies, Monoclonal | 42 | 2021 | 839 | 1.150 |
Why?
|
T-Lymphocytes | 46 | 2012 | 986 | 1.050 |
Why?
|
Membrane Glycoproteins | 39 | 2005 | 661 | 1.040 |
Why?
|
Graft Survival | 22 | 2007 | 290 | 0.970 |
Why?
|
Skin Transplantation | 24 | 2007 | 155 | 0.950 |
Why?
|
ADP Ribose Transferases | 24 | 2006 | 62 | 0.940 |
Why?
|
Islets of Langerhans Transplantation | 21 | 2006 | 174 | 0.910 |
Why?
|
Autoimmune Diseases | 26 | 2006 | 220 | 0.820 |
Why?
|
Animals | 164 | 2021 | 19651 | 0.820 |
Why?
|
Hyperinsulinism | 2 | 2015 | 25 | 0.810 |
Why?
|
Chromosome Mapping | 8 | 2009 | 284 | 0.770 |
Why?
|
Hypoglycemia | 2 | 2015 | 66 | 0.760 |
Why?
|
Rats, Inbred Strains | 32 | 2013 | 150 | 0.710 |
Why?
|
CD40 Ligand | 31 | 2006 | 156 | 0.660 |
Why?
|
Poly I-C | 16 | 2013 | 76 | 0.660 |
Why?
|
Disease Models, Animal | 21 | 2014 | 2050 | 0.620 |
Why?
|
Diabetes Mellitus | 10 | 2011 | 515 | 0.580 |
Why?
|
Transplantation, Heterologous | 8 | 2006 | 223 | 0.580 |
Why?
|
Parvovirus | 7 | 2016 | 24 | 0.550 |
Why?
|
Immune Tolerance | 13 | 2008 | 172 | 0.530 |
Why?
|
Islets of Langerhans | 21 | 2013 | 271 | 0.520 |
Why?
|
Parvoviridae Infections | 4 | 2009 | 23 | 0.500 |
Why?
|
Transplantation Tolerance | 10 | 2009 | 65 | 0.500 |
Why?
|
Blood Glucose | 6 | 2021 | 461 | 0.500 |
Why?
|
Drugs, Chinese Herbal | 1 | 2015 | 9 | 0.480 |
Why?
|
Anti-Obesity Agents | 1 | 2015 | 14 | 0.480 |
Why?
|
Blood Transfusion | 14 | 2004 | 150 | 0.480 |
Why?
|
Histocompatibility Antigens | 20 | 2001 | 107 | 0.460 |
Why?
|
Gastric Bypass | 1 | 2015 | 74 | 0.450 |
Why?
|
T-Lymphocyte Subsets | 9 | 2013 | 244 | 0.450 |
Why?
|
Weight Loss | 2 | 2015 | 263 | 0.420 |
Why?
|
Thymus Gland | 17 | 2009 | 229 | 0.420 |
Why?
|
Rats, Inbred Lew | 11 | 2021 | 106 | 0.420 |
Why?
|
Pancreas | 9 | 2003 | 147 | 0.410 |
Why?
|
Spleen | 31 | 2009 | 480 | 0.400 |
Why?
|
CD4-Positive T-Lymphocytes | 14 | 2009 | 620 | 0.400 |
Why?
|
Lymphocyte Activation | 22 | 2009 | 743 | 0.390 |
Why?
|
Major Histocompatibility Complex | 4 | 2009 | 86 | 0.380 |
Why?
|
Insulin | 9 | 2021 | 674 | 0.380 |
Why?
|
CD8-Positive T-Lymphocytes | 17 | 2021 | 648 | 0.380 |
Why?
|
Mice, Inbred C57BL | 36 | 2009 | 3231 | 0.350 |
Why?
|
Endothelium, Vascular | 4 | 1996 | 169 | 0.340 |
Why?
|
Nifedipine | 1 | 2010 | 18 | 0.340 |
Why?
|
Mice, Inbred NOD | 16 | 2009 | 516 | 0.340 |
Why?
|
Mice | 63 | 2010 | 10292 | 0.330 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2021 | 439 | 0.330 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 26 | 2001 | 105 | 0.330 |
Why?
|
Lymphocyte Depletion | 18 | 2004 | 99 | 0.330 |
Why?
|
Graft Rejection | 14 | 2006 | 289 | 0.320 |
Why?
|
Virus Diseases | 3 | 2009 | 114 | 0.320 |
Why?
|
Immunization | 1 | 2009 | 128 | 0.320 |
Why?
|
Female | 70 | 2019 | 30705 | 0.310 |
Why?
|
Mice, Inbred BALB C | 25 | 2010 | 868 | 0.310 |
Why?
|
Male | 71 | 2019 | 27739 | 0.310 |
Why?
|
Killer Cells, Natural | 8 | 2004 | 218 | 0.300 |
Why?
|
Transplantation Immunology | 4 | 2007 | 27 | 0.300 |
Why?
|
Genotype | 4 | 2021 | 617 | 0.290 |
Why?
|
Immunoglobulin Variable Region | 1 | 2007 | 31 | 0.280 |
Why?
|
Obesity | 1 | 2015 | 1166 | 0.280 |
Why?
|
Insulin-Secreting Cells | 3 | 2021 | 178 | 0.260 |
Why?
|
Alleles | 6 | 2019 | 411 | 0.260 |
Why?
|
Prediabetic State | 4 | 2019 | 51 | 0.260 |
Why?
|
Rats, Inbred WF | 21 | 2004 | 56 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2019 | 635 | 0.240 |
Why?
|
Transplantation, Homologous | 18 | 2007 | 244 | 0.240 |
Why?
|
Transplantation Chimera | 4 | 2007 | 39 | 0.230 |
Why?
|
Immunogenetics | 1 | 2004 | 4 | 0.220 |
Why?
|
CD3 Complex | 4 | 2021 | 63 | 0.220 |
Why?
|
Lymphopenia | 7 | 2009 | 35 | 0.220 |
Why?
|
Lymphocyte Transfusion | 10 | 2003 | 37 | 0.210 |
Why?
|
Bone Marrow Transplantation | 7 | 2007 | 138 | 0.210 |
Why?
|
GTP-Binding Proteins | 3 | 2009 | 81 | 0.210 |
Why?
|
Interferon Type I | 3 | 2016 | 169 | 0.210 |
Why?
|
Receptors, Antigen, T-Cell | 5 | 2021 | 281 | 0.200 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2016 | 45 | 0.200 |
Why?
|
Lymphocytes | 7 | 2003 | 190 | 0.200 |
Why?
|
Antigens, CD | 5 | 2021 | 343 | 0.200 |
Why?
|
Signal Transduction | 10 | 2010 | 2902 | 0.200 |
Why?
|
Hematopoiesis | 5 | 2007 | 120 | 0.200 |
Why?
|
Interferon-gamma | 11 | 2009 | 551 | 0.200 |
Why?
|
Isoantigens | 10 | 2007 | 71 | 0.200 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2021 | 182 | 0.200 |
Why?
|
Mice, Inbred CBA | 12 | 2007 | 83 | 0.190 |
Why?
|
Gene Expression Regulation | 6 | 2013 | 1552 | 0.190 |
Why?
|
Genetic Linkage | 4 | 2009 | 93 | 0.190 |
Why?
|
Humans | 41 | 2019 | 59360 | 0.180 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2021 | 19 | 0.180 |
Why?
|
Organometallic Compounds | 2 | 1993 | 63 | 0.180 |
Why?
|
Indoles | 2 | 1993 | 107 | 0.180 |
Why?
|
Autoantibodies | 7 | 1996 | 172 | 0.180 |
Why?
|
Hyaluronic Acid | 1 | 2021 | 66 | 0.170 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2007 | 207 | 0.170 |
Why?
|
Cytokines | 6 | 2003 | 912 | 0.170 |
Why?
|
Cells, Cultured | 14 | 2016 | 2093 | 0.160 |
Why?
|
HLA-DR alpha-Chains | 1 | 2019 | 3 | 0.160 |
Why?
|
HLA-DR3 Antigen | 1 | 2019 | 6 | 0.160 |
Why?
|
Resistance Training | 1 | 2019 | 19 | 0.160 |
Why?
|
Peptide Fragments | 1 | 2021 | 400 | 0.160 |
Why?
|
Exercise Therapy | 1 | 2019 | 99 | 0.150 |
Why?
|
Protein Binding | 2 | 2021 | 1557 | 0.150 |
Why?
|
Time Factors | 15 | 2019 | 3617 | 0.140 |
Why?
|
Mice, SCID | 7 | 2007 | 513 | 0.140 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 168 | 0.140 |
Why?
|
Stress, Physiological | 4 | 2009 | 185 | 0.140 |
Why?
|
Genetic Markers | 5 | 2004 | 116 | 0.140 |
Why?
|
Immunosuppressive Agents | 5 | 2003 | 365 | 0.140 |
Why?
|
Clonal Anergy | 2 | 2009 | 23 | 0.140 |
Why?
|
Antigens | 4 | 2010 | 146 | 0.130 |
Why?
|
Immunity, Innate | 12 | 2016 | 774 | 0.130 |
Why?
|
CD40 Antigens | 8 | 2006 | 61 | 0.130 |
Why?
|
Immunization, Passive | 9 | 1994 | 99 | 0.120 |
Why?
|
Antigens, Differentiation | 4 | 2000 | 137 | 0.120 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 102 | 0.120 |
Why?
|
Toll-Like Receptors | 3 | 2006 | 426 | 0.120 |
Why?
|
Disease Susceptibility | 10 | 2014 | 157 | 0.120 |
Why?
|
Crosses, Genetic | 5 | 2007 | 105 | 0.120 |
Why?
|
Venules | 3 | 1993 | 8 | 0.120 |
Why?
|
Adoptive Transfer | 7 | 2006 | 147 | 0.120 |
Why?
|
Antibodies | 3 | 2006 | 179 | 0.120 |
Why?
|
Immunoconjugates | 3 | 2000 | 85 | 0.120 |
Why?
|
Apoptosis | 6 | 2009 | 1032 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 5 | 2004 | 147 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 121 | 0.110 |
Why?
|
Receptors, Interleukin-2 | 6 | 2003 | 71 | 0.110 |
Why?
|
Coloring Agents | 2 | 1999 | 53 | 0.110 |
Why?
|
Homozygote | 4 | 2019 | 114 | 0.110 |
Why?
|
Parvovirinae | 1 | 2014 | 3 | 0.110 |
Why?
|
Exercise | 2 | 2019 | 883 | 0.110 |
Why?
|
Graft vs Host Disease | 4 | 2003 | 105 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 1994 | 85 | 0.110 |
Why?
|
Ubiquitins | 1 | 2014 | 41 | 0.110 |
Why?
|
Species Specificity | 10 | 2003 | 329 | 0.110 |
Why?
|
Liver | 4 | 2006 | 797 | 0.110 |
Why?
|
Interleukin-4 | 6 | 2009 | 145 | 0.110 |
Why?
|
Poly(ADP-ribose) Polymerases | 5 | 2001 | 31 | 0.110 |
Why?
|
Prostaglandins | 1 | 1993 | 17 | 0.110 |
Why?
|
Disease Resistance | 1 | 2013 | 23 | 0.110 |
Why?
|
Anorexia | 2 | 1984 | 6 | 0.110 |
Why?
|
Leydig Cell Tumor | 2 | 1984 | 3 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 3 | 2007 | 238 | 0.100 |
Why?
|
Flow Cytometry | 8 | 2006 | 644 | 0.100 |
Why?
|
Transplantation Conditioning | 5 | 2006 | 98 | 0.100 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 428 | 0.100 |
Why?
|
Mice, Knockout | 10 | 2014 | 1994 | 0.100 |
Why?
|
Diabetes Complications | 2 | 2011 | 100 | 0.100 |
Why?
|
RNA, Messenger | 5 | 2012 | 1465 | 0.100 |
Why?
|
Feeding and Eating Disorders | 2 | 1984 | 49 | 0.100 |
Why?
|
Intestinal Mucosa | 3 | 2004 | 225 | 0.100 |
Why?
|
Immunophenotyping | 7 | 2001 | 184 | 0.090 |
Why?
|
Vaccinia virus | 2 | 2009 | 70 | 0.090 |
Why?
|
Cultural Competency | 1 | 2011 | 47 | 0.090 |
Why?
|
Comorbidity | 1 | 2015 | 1078 | 0.090 |
Why?
|
Glucose Tolerance Test | 2 | 2011 | 96 | 0.090 |
Why?
|
DNA Primers | 3 | 2009 | 289 | 0.090 |
Why?
|
Lymphocytic Choriomeningitis | 2 | 2002 | 53 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1993 | 202 | 0.090 |
Why?
|
Toll-Like Receptor 3 | 3 | 2007 | 65 | 0.090 |
Why?
|
Lymphoid Tissue | 4 | 2002 | 55 | 0.090 |
Why?
|
Models, Animal | 2 | 2009 | 221 | 0.090 |
Why?
|
Genetic Testing | 1 | 2012 | 126 | 0.090 |
Why?
|
Radiation Chimera | 4 | 2006 | 57 | 0.090 |
Why?
|
Haptoglobins | 1 | 2010 | 11 | 0.090 |
Why?
|
Secretory Vesicles | 1 | 2010 | 21 | 0.090 |
Why?
|
Community Health Services | 1 | 2011 | 120 | 0.090 |
Why?
|
Base Sequence | 4 | 2009 | 1302 | 0.090 |
Why?
|
NAD | 3 | 2001 | 50 | 0.090 |
Why?
|
Bone Marrow | 7 | 2002 | 177 | 0.090 |
Why?
|
Transcriptome | 1 | 2013 | 340 | 0.080 |
Why?
|
Cell Membrane Permeability | 1 | 1990 | 39 | 0.080 |
Why?
|
Centrosome | 1 | 2010 | 71 | 0.080 |
Why?
|
Cell Differentiation | 7 | 2004 | 1304 | 0.080 |
Why?
|
Enterovirus Infections | 1 | 2009 | 11 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 1997 | 170 | 0.080 |
Why?
|
Enterovirus B, Human | 1 | 2009 | 17 | 0.080 |
Why?
|
Veins | 1 | 1990 | 61 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2009 | 6 | 0.080 |
Why?
|
Aging | 6 | 2001 | 710 | 0.080 |
Why?
|
Adenosine Diphosphate Ribose | 5 | 2006 | 15 | 0.080 |
Why?
|
Interleukin-2 | 5 | 2009 | 164 | 0.080 |
Why?
|
Galactosylceramides | 1 | 2009 | 11 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2009 | 66 | 0.080 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2006 | 10 | 0.080 |
Why?
|
Biomarkers | 2 | 2011 | 1306 | 0.080 |
Why?
|
Haplotypes | 1 | 2009 | 115 | 0.080 |
Why?
|
Lipopolysaccharides | 3 | 2007 | 627 | 0.080 |
Why?
|
Body Weight | 5 | 1990 | 368 | 0.070 |
Why?
|
CD8 Antigens | 7 | 2003 | 53 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 146 | 0.070 |
Why?
|
Antibodies, Blocking | 3 | 2003 | 40 | 0.070 |
Why?
|
Dendritic Cells | 4 | 2004 | 515 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 1093 | 0.070 |
Why?
|
Lymph Nodes | 9 | 2003 | 214 | 0.070 |
Why?
|
Membrane Proteins | 3 | 2007 | 850 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2004 | 697 | 0.070 |
Why?
|
Mice, Inbred C3H | 6 | 2007 | 173 | 0.070 |
Why?
|
Macrophages | 6 | 2021 | 1015 | 0.070 |
Why?
|
Protein Kinase C | 1 | 2008 | 98 | 0.070 |
Why?
|
Middle Aged | 5 | 2019 | 16317 | 0.070 |
Why?
|
Cell Survival | 6 | 2009 | 559 | 0.070 |
Why?
|
Health Promotion | 1 | 2011 | 471 | 0.070 |
Why?
|
China | 2 | 2019 | 134 | 0.070 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 25 | 0.070 |
Why?
|
Leukocyte Transfusion | 2 | 2004 | 16 | 0.070 |
Why?
|
Combined Modality Therapy | 6 | 2004 | 355 | 0.070 |
Why?
|
Health | 1 | 2007 | 31 | 0.070 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 234 | 0.070 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2006 | 3 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1987 | 109 | 0.060 |
Why?
|
Cell Membrane | 2 | 2006 | 486 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2006 | 125 | 0.060 |
Why?
|
Interleukins | 3 | 2010 | 80 | 0.060 |
Why?
|
Growth Inhibitors | 1 | 2006 | 25 | 0.060 |
Why?
|
Concanavalin A | 5 | 2003 | 40 | 0.060 |
Why?
|
Pancreatitis | 4 | 1999 | 95 | 0.060 |
Why?
|
Toll-Like Receptor 9 | 1 | 2007 | 202 | 0.060 |
Why?
|
Blotting, Western | 6 | 2010 | 584 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2002 | 806 | 0.060 |
Why?
|
Arthritis | 1 | 2005 | 49 | 0.060 |
Why?
|
Risk Factors | 1 | 2015 | 4984 | 0.060 |
Why?
|
Aged | 4 | 2019 | 13416 | 0.060 |
Why?
|
Collagen | 1 | 2005 | 115 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 527 | 0.060 |
Why?
|
NAD+ Nucleosidase | 2 | 2001 | 10 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2006 | 225 | 0.060 |
Why?
|
Treatment Outcome | 1 | 2015 | 5284 | 0.060 |
Why?
|
Treatment Failure | 1 | 2005 | 185 | 0.060 |
Why?
|
Lectins, C-Type | 2 | 2002 | 88 | 0.060 |
Why?
|
Adolescent | 1 | 2015 | 5824 | 0.060 |
Why?
|
Up-Regulation | 3 | 2013 | 365 | 0.060 |
Why?
|
Rats, Mutant Strains | 2 | 2002 | 10 | 0.050 |
Why?
|
Lymphocyte Count | 5 | 2004 | 68 | 0.050 |
Why?
|
Adult | 3 | 2015 | 15669 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2006 | 1206 | 0.050 |
Why?
|
Microcirculation | 2 | 1996 | 52 | 0.050 |
Why?
|
Rats, Nude | 6 | 2001 | 25 | 0.050 |
Why?
|
Estradiol | 1 | 1984 | 247 | 0.050 |
Why?
|
Thyroiditis | 4 | 1996 | 11 | 0.050 |
Why?
|
Pregnancy | 2 | 2009 | 2202 | 0.050 |
Why?
|
Pancreatic Polypeptide | 1 | 1982 | 10 | 0.050 |
Why?
|
Pancreatic Diseases | 1 | 2002 | 39 | 0.050 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 8 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2003 | 100 | 0.050 |
Why?
|
Interleukin-12 | 2 | 2009 | 123 | 0.050 |
Why?
|
Mice, Obese | 1 | 1982 | 80 | 0.050 |
Why?
|
Tissue Donors | 5 | 2003 | 143 | 0.050 |
Why?
|
Recombinant Proteins | 5 | 2006 | 689 | 0.050 |
Why?
|
Diarrhea | 1 | 1982 | 75 | 0.050 |
Why?
|
Pyrophosphatases | 1 | 2001 | 11 | 0.050 |
Why?
|
GPI-Linked Proteins | 2 | 1999 | 39 | 0.050 |
Why?
|
Recurrence | 4 | 2006 | 603 | 0.050 |
Why?
|
Models, Immunological | 1 | 2001 | 85 | 0.050 |
Why?
|
Thymectomy | 5 | 2000 | 34 | 0.050 |
Why?
|
Immunity, Mucosal | 1 | 2001 | 49 | 0.050 |
Why?
|
Testicular Neoplasms | 1 | 1981 | 32 | 0.050 |
Why?
|
Genetic Variation | 2 | 2019 | 357 | 0.050 |
Why?
|
Cell Line | 6 | 2009 | 1984 | 0.050 |
Why?
|
RNA, Small Interfering | 4 | 2010 | 857 | 0.050 |
Why?
|
Diet | 2 | 2011 | 497 | 0.050 |
Why?
|
Phenotype | 7 | 2009 | 1137 | 0.050 |
Why?
|
Antigens, Surface | 4 | 2009 | 192 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2002 | 162 | 0.040 |
Why?
|
Thyroiditis, Autoimmune | 2 | 1990 | 8 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 349 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 205 | 0.040 |
Why?
|
Mitochondria | 1 | 2003 | 343 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2000 | 88 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2001 | 279 | 0.040 |
Why?
|
Animals, Newborn | 4 | 2004 | 230 | 0.040 |
Why?
|
CD28 Antigens | 3 | 2006 | 60 | 0.040 |
Why?
|
Leukocyte Common Antigens | 3 | 2006 | 58 | 0.040 |
Why?
|
Age Factors | 5 | 2013 | 1504 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2002 | 328 | 0.040 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1999 | 6 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1999 | 15 | 0.040 |
Why?
|
Gene Frequency | 1 | 2019 | 118 | 0.040 |
Why?
|
Multigene Family | 1 | 1999 | 92 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 446 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2001 | 411 | 0.040 |
Why?
|
Cattle | 2 | 1997 | 304 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 81 | 0.040 |
Why?
|
Introns | 1 | 2019 | 104 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2009 | 942 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 1998 | 35 | 0.040 |
Why?
|
Immunotherapy, Adoptive | 4 | 1995 | 87 | 0.040 |
Why?
|
Heat-Shock Proteins | 2 | 2009 | 65 | 0.040 |
Why?
|
Cricetinae | 3 | 2006 | 366 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 1151 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2008 | 359 | 0.040 |
Why?
|
Proteins | 2 | 2002 | 730 | 0.040 |
Why?
|
Molecular Chaperones | 2 | 2009 | 99 | 0.040 |
Why?
|
Gene Expression | 3 | 2014 | 809 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2010 | 844 | 0.040 |
Why?
|
Isoantibodies | 2 | 1996 | 33 | 0.040 |
Why?
|
Injections, Intraperitoneal | 3 | 2003 | 46 | 0.040 |
Why?
|
Milk | 1 | 1997 | 39 | 0.030 |
Why?
|
Milk Proteins | 1 | 1997 | 44 | 0.030 |
Why?
|
Caseins | 1 | 1997 | 41 | 0.030 |
Why?
|
Organ Culture Techniques | 3 | 2003 | 68 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2013 | 1554 | 0.030 |
Why?
|
Transcription Factors | 1 | 2004 | 1471 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 3 | 2010 | 217 | 0.030 |
Why?
|
Interferons | 2 | 1994 | 61 | 0.030 |
Why?
|
src-Family Kinases | 1 | 1996 | 60 | 0.030 |
Why?
|
Protein Biosynthesis | 2 | 2002 | 297 | 0.030 |
Why?
|
Catalysis | 3 | 2006 | 152 | 0.030 |
Why?
|
Chimera | 2 | 1997 | 40 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2019 | 1051 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 191 | 0.030 |
Why?
|
Terminology as Topic | 3 | 1999 | 133 | 0.030 |
Why?
|
Thyroid Gland | 1 | 1996 | 79 | 0.030 |
Why?
|
Polymerase Chain Reaction | 4 | 1999 | 495 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 2 | 2007 | 339 | 0.030 |
Why?
|
Silicon Dioxide | 2 | 1999 | 60 | 0.030 |
Why?
|
Autoantigens | 2 | 2013 | 129 | 0.030 |
Why?
|
Abatacept | 3 | 2000 | 64 | 0.030 |
Why?
|
Swine | 1 | 1996 | 352 | 0.030 |
Why?
|
CTLA-4 Antigen | 3 | 2000 | 70 | 0.030 |
Why?
|
Administration, Oral | 1 | 1996 | 356 | 0.030 |
Why?
|
Interferon Inducers | 2 | 2007 | 11 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 1994 | 6 | 0.030 |
Why?
|
Cell Division | 3 | 2003 | 443 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2010 | 1370 | 0.030 |
Why?
|
Cytotoxins | 1 | 1994 | 12 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2014 | 62 | 0.030 |
Why?
|
Sex Factors | 2 | 2009 | 935 | 0.030 |
Why?
|
In Vitro Techniques | 4 | 1999 | 471 | 0.030 |
Why?
|
Adipose Tissue | 1 | 1996 | 283 | 0.030 |
Why?
|
Disease Management | 1 | 2015 | 221 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 192 | 0.030 |
Why?
|
Interleukin-1 | 2 | 2010 | 157 | 0.030 |
Why?
|
Solubility | 3 | 2001 | 177 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 1996 | 179 | 0.030 |
Why?
|
Prostaglandins E | 1 | 1993 | 8 | 0.030 |
Why?
|
Ketorolac | 1 | 1993 | 11 | 0.030 |
Why?
|
Tolmetin | 1 | 1993 | 10 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1993 | 15 | 0.030 |
Why?
|
Clone Cells | 2 | 2004 | 106 | 0.030 |
Why?
|
Ibuprofen | 1 | 1993 | 18 | 0.030 |
Why?
|
Misoprostol | 1 | 1993 | 8 | 0.030 |
Why?
|
Blood Pressure | 1 | 2015 | 495 | 0.030 |
Why?
|
Environment | 2 | 1991 | 119 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2013 | 280 | 0.030 |
Why?
|
CRISPR-Cas Systems | 1 | 2016 | 333 | 0.030 |
Why?
|
Injections, Intravenous | 2 | 2003 | 155 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 149 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 1997 | 1952 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 170 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 2 | 2002 | 8 | 0.020 |
Why?
|
Lod Score | 2 | 2004 | 23 | 0.020 |
Why?
|
Coculture Techniques | 2 | 2003 | 95 | 0.020 |
Why?
|
Microsatellite Repeats | 2 | 2004 | 38 | 0.020 |
Why?
|
Antibody Specificity | 2 | 2003 | 100 | 0.020 |
Why?
|
Body Mass Index | 1 | 2015 | 831 | 0.020 |
Why?
|
Hematopoietic System | 1 | 1991 | 10 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 2 | 2004 | 70 | 0.020 |
Why?
|
Models, Biological | 4 | 2008 | 1143 | 0.020 |
Why?
|
DNA, Viral | 2 | 2007 | 223 | 0.020 |
Why?
|
Virus Physiological Phenomena | 1 | 1991 | 7 | 0.020 |
Why?
|
B7-1 Antigen | 2 | 2003 | 73 | 0.020 |
Why?
|
Disease Progression | 2 | 2010 | 1122 | 0.020 |
Why?
|
Azathioprine | 1 | 1991 | 27 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 651 | 0.020 |
Why?
|
CD4 Antigens | 2 | 2003 | 148 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 3 | 2001 | 276 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 39 | 0.020 |
Why?
|
Cyclosporine | 1 | 1991 | 76 | 0.020 |
Why?
|
Rats, Inbred BN | 1 | 2010 | 25 | 0.020 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2003 | 176 | 0.020 |
Why?
|
Prednisone | 1 | 1991 | 85 | 0.020 |
Why?
|
Smoking | 1 | 2015 | 826 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2010 | 63 | 0.020 |
Why?
|
Antibody Formation | 1 | 1991 | 108 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 27 | 0.020 |
Why?
|
Homeostasis | 2 | 2010 | 346 | 0.020 |
Why?
|
Genes | 1 | 1990 | 90 | 0.020 |
Why?
|
Kinetics | 2 | 2002 | 751 | 0.020 |
Why?
|
Aziridines | 1 | 1990 | 3 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 718 | 0.020 |
Why?
|
Fatty Acids, Essential | 1 | 1990 | 8 | 0.020 |
Why?
|
HIV-1 | 1 | 1995 | 692 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 133 | 0.020 |
Why?
|
Carrageenan | 1 | 1990 | 17 | 0.020 |
Why?
|
Life Style | 1 | 2011 | 299 | 0.020 |
Why?
|
Poverty | 1 | 2011 | 281 | 0.020 |
Why?
|
B-Lymphocytes | 2 | 2007 | 550 | 0.020 |
Why?
|
Columbidae | 1 | 2009 | 11 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 741 | 0.020 |
Why?
|
Genome | 2 | 2004 | 257 | 0.020 |
Why?
|
Cytochromes c | 1 | 2009 | 26 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1990 | 124 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2010 | 258 | 0.020 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2009 | 56 | 0.020 |
Why?
|
Phosphorylation | 2 | 2004 | 884 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 194 | 0.020 |
Why?
|
HIV Infections | 1 | 1995 | 913 | 0.020 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 2008 | 5 | 0.020 |
Why?
|
Thapsigargin | 1 | 2008 | 17 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2011 | 392 | 0.020 |
Why?
|
Ionomycin | 1 | 2008 | 15 | 0.020 |
Why?
|
Health Behavior | 1 | 2011 | 451 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 33 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2003 | 847 | 0.020 |
Why?
|
Ligands | 2 | 2000 | 411 | 0.020 |
Why?
|
Immune System | 1 | 1989 | 129 | 0.020 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2001 | 29 | 0.020 |
Why?
|
Castration | 2 | 1984 | 41 | 0.020 |
Why?
|
CD5 Antigens | 2 | 2001 | 18 | 0.020 |
Why?
|
Spodoptera | 2 | 1997 | 27 | 0.020 |
Why?
|
Breeding | 1 | 2007 | 26 | 0.020 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2007 | 16 | 0.020 |
Why?
|
Transfection | 1 | 2009 | 675 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 12 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2007 | 202 | 0.020 |
Why?
|
Chloroquine | 1 | 2007 | 50 | 0.020 |
Why?
|
Telomere | 1 | 2007 | 50 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2008 | 172 | 0.020 |
Why?
|
Fluoresceins | 1 | 2006 | 29 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2006 | 17 | 0.020 |
Why?
|
Structural Homology, Protein | 1 | 2006 | 20 | 0.020 |
Why?
|
Host vs Graft Reaction | 1 | 2006 | 3 | 0.020 |
Why?
|
Subrenal Capsule Assay | 1 | 2006 | 3 | 0.020 |
Why?
|
Forecasting | 1 | 1987 | 219 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2006 | 33 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 1999 | 490 | 0.020 |
Why?
|
Receptors, Interleukin-12 | 1 | 2006 | 9 | 0.020 |
Why?
|
Clonal Deletion | 1 | 2006 | 11 | 0.020 |
Why?
|
Genome, Viral | 1 | 2007 | 120 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2006 | 30 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2006 | 39 | 0.020 |
Why?
|
Massachusetts | 1 | 2011 | 2002 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 2003 | 171 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2007 | 310 | 0.020 |
Why?
|
Isoenzymes | 2 | 2001 | 136 | 0.020 |
Why?
|
Parvoviridae | 1 | 2005 | 5 | 0.020 |
Why?
|
Thymidine | 2 | 1996 | 25 | 0.020 |
Why?
|
Metrizamide | 1 | 2004 | 4 | 0.010 |
Why?
|
Early Growth Response Protein 2 | 1 | 2004 | 8 | 0.010 |
Why?
|
Vaccinia | 1 | 2005 | 31 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 657 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2005 | 64 | 0.010 |
Why?
|
NF-kappa B | 1 | 2007 | 460 | 0.010 |
Why?
|
Parabiosis | 1 | 1984 | 2 | 0.010 |
Why?
|
Rats, Zucker | 1 | 1984 | 7 | 0.010 |
Why?
|
Estrone | 1 | 1984 | 12 | 0.010 |
Why?
|
Hypothalamus, Middle | 1 | 1984 | 20 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 70 | 0.010 |
Why?
|
Immunocompetence | 1 | 2004 | 20 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1984 | 52 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2004 | 96 | 0.010 |
Why?
|
Lymphopoiesis | 1 | 2004 | 27 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1984 | 161 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2004 | 2 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 588 | 0.010 |
Why?
|
Adjuvants, Immunologic | 2 | 1999 | 224 | 0.010 |
Why?
|
Testosterone | 1 | 1984 | 112 | 0.010 |
Why?
|
Myocardium | 1 | 1985 | 264 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1996 | 178 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2003 | 35 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 2003 | 16 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 2003 | 48 | 0.010 |
Why?
|
B7-2 Antigen | 1 | 2003 | 32 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 1994 | 51 | 0.010 |
Why?
|
Lymphocytosis | 1 | 2003 | 3 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 2003 | 40 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 127 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 137 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2003 | 207 | 0.010 |
Why?
|
Interleukin-18 | 1 | 2003 | 71 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 2002 | 19 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2004 | 574 | 0.010 |
Why?
|
Mitosis | 1 | 1984 | 208 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 1128 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 2003 | 177 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 135 | 0.010 |
Why?
|
Antigens, Ly | 1 | 2002 | 42 | 0.010 |
Why?
|
Caspases | 1 | 2003 | 166 | 0.010 |
Why?
|
DNA | 2 | 1997 | 806 | 0.010 |
Why?
|
Gene Silencing | 1 | 2004 | 378 | 0.010 |
Why?
|
Immunotherapy | 1 | 2004 | 230 | 0.010 |
Why?
|
Reference Values | 2 | 1994 | 326 | 0.010 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2001 | 5 | 0.010 |
Why?
|
H-2 Antigens | 1 | 2001 | 64 | 0.010 |
Why?
|
Cholera Toxin | 1 | 2001 | 7 | 0.010 |
Why?
|
Mitogens | 1 | 2001 | 10 | 0.010 |
Why?
|
Phosphorus Radioisotopes | 1 | 2001 | 14 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2001 | 14 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 2001 | 14 | 0.010 |
Why?
|
Energy Metabolism | 1 | 1984 | 359 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 2001 | 40 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2001 | 33 | 0.010 |
Why?
|
Adenosine Monophosphate | 1 | 2001 | 27 | 0.010 |
Why?
|
Viral Load | 1 | 2002 | 220 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 1983 | 137 | 0.010 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 2001 | 33 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 2001 | 33 | 0.010 |
Why?
|
Alloxan | 1 | 1981 | 1 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2001 | 179 | 0.010 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2001 | 19 | 0.010 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 1981 | 62 | 0.010 |
Why?
|
Serologic Tests | 1 | 2001 | 34 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1981 | 75 | 0.010 |
Why?
|
Streptozocin | 1 | 1981 | 21 | 0.010 |
Why?
|
Macaca | 1 | 1981 | 29 | 0.010 |
Why?
|
Adenosine | 1 | 2001 | 70 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2003 | 292 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2001 | 53 | 0.010 |
Why?
|
Cell Lineage | 1 | 2002 | 259 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1981 | 102 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2001 | 127 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 450 | 0.010 |
Why?
|
Hormones | 1 | 1981 | 60 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 98 | 0.010 |
Why?
|
Hypothalamus | 1 | 1981 | 129 | 0.010 |
Why?
|
Leukocyte Count | 2 | 1994 | 97 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2000 | 43 | 0.010 |
Why?
|
Pichinde virus | 1 | 2000 | 20 | 0.010 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 1991 | 67 | 0.010 |
Why?
|
Mice, Mutant Strains | 2 | 1991 | 297 | 0.010 |
Why?
|
Dogs | 1 | 1981 | 314 | 0.010 |
Why?
|
Povidone | 1 | 1999 | 8 | 0.010 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 1999 | 10 | 0.010 |
Why?
|
Thy-1 Antigens | 1 | 1999 | 21 | 0.010 |
Why?
|
Age of Onset | 1 | 1999 | 170 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2001 | 281 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 1999 | 35 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1999 | 36 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 84 | 0.010 |
Why?
|
Second Messenger Systems | 1 | 1999 | 26 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2000 | 98 | 0.010 |
Why?
|
Hybridization, Genetic | 1 | 1999 | 14 | 0.010 |
Why?
|
Peyer's Patches | 1 | 1999 | 36 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 1998 | 28 | 0.010 |
Why?
|
Cell Transplantation | 1 | 1998 | 39 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1999 | 287 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1998 | 65 | 0.010 |
Why?
|
Cellular Senescence | 1 | 1999 | 104 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 1998 | 126 | 0.010 |
Why?
|
Intestine, Small | 1 | 1998 | 77 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 283 | 0.010 |
Why?
|
Serum Albumin | 1 | 1997 | 45 | 0.010 |
Why?
|
Baculoviridae | 1 | 1997 | 26 | 0.010 |
Why?
|
Cell Movement | 1 | 1999 | 429 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1997 | 225 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1997 | 76 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 288 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1996 | 65 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1999 | 391 | 0.010 |
Why?
|
Rats, Inbred BUF | 2 | 1986 | 10 | 0.010 |
Why?
|
Immunoblotting | 1 | 1996 | 188 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 863 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1996 | 117 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1994 | 55 | 0.010 |
Why?
|
Epithelium | 1 | 1994 | 96 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1994 | 52 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 148 | 0.010 |
Why?
|
Incidence | 1 | 1997 | 1237 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1994 | 214 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1993 | 48 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 73 | 0.010 |
Why?
|
Organ Specificity | 1 | 1993 | 183 | 0.010 |
Why?
|
Cell Communication | 1 | 1993 | 124 | 0.010 |
Why?
|
Killer Factors, Yeast | 1 | 1991 | 3 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1991 | 76 | 0.010 |
Why?
|
Causality | 1 | 1991 | 57 | 0.010 |
Why?
|
Radioligand Assay | 1 | 1990 | 24 | 0.010 |
Why?
|
Linoleic Acids | 1 | 1990 | 8 | 0.010 |
Why?
|
Thyrotropin | 1 | 1990 | 34 | 0.010 |
Why?
|
Linoleic Acid | 1 | 1990 | 18 | 0.010 |
Why?
|
Viruses | 1 | 1991 | 78 | 0.010 |
Why?
|
Thyroxine | 1 | 1990 | 52 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1990 | 89 | 0.010 |
Why?
|
Lymphoma | 1 | 1990 | 99 | 0.010 |
Why?
|
Child, Preschool | 1 | 1995 | 1782 | 0.010 |
Why?
|
RNA | 1 | 1993 | 401 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1991 | 207 | 0.000 |
Why?
|
Regression Analysis | 1 | 1990 | 485 | 0.000 |
Why?
|
Gamma Rays | 1 | 1989 | 31 | 0.000 |
Why?
|
Biological Factors | 1 | 1989 | 21 | 0.000 |
Why?
|
Radiation Tolerance | 1 | 1989 | 49 | 0.000 |
Why?
|
Fatty Acids | 1 | 1990 | 190 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1988 | 31 | 0.000 |
Why?
|
Ultraviolet Rays | 1 | 1989 | 127 | 0.000 |
Why?
|
Endothelium | 1 | 1987 | 18 | 0.000 |
Why?
|
Inflammation | 1 | 1994 | 1099 | 0.000 |
Why?
|
Macrophage Activation | 1 | 1987 | 118 | 0.000 |
Why?
|
Glucose | 1 | 1990 | 445 | 0.000 |
Why?
|
DNA Replication | 1 | 1987 | 228 | 0.000 |
Why?
|
Child | 1 | 1995 | 4174 | 0.000 |
Why?
|
Culture Media | 1 | 1985 | 77 | 0.000 |
Why?
|
Monocytes | 1 | 1987 | 345 | 0.000 |
Why?
|
Rats, Brattleboro | 1 | 1985 | 2 | 0.000 |
Why?
|
Lymphokines | 1 | 1985 | 65 | 0.000 |
Why?
|
Brain | 1 | 1993 | 1488 | 0.000 |
Why?
|
HLA Antigens | 1 | 1985 | 61 | 0.000 |
Why?
|
Cardiomyopathies | 1 | 1985 | 119 | 0.000 |
Why?
|
Adenosine Triphosphatases | 1 | 1985 | 253 | 0.000 |
Why?
|
Hypophysectomy | 1 | 1983 | 2 | 0.000 |
Why?
|
Methylglucosides | 1 | 1983 | 4 | 0.000 |
Why?
|
Vagotomy | 1 | 1983 | 8 | 0.000 |
Why?
|
3-O-Methylglucose | 1 | 1983 | 16 | 0.000 |
Why?
|
Niacinamide | 1 | 1983 | 32 | 0.000 |
Why?
|
Pregnancy in Diabetics | 1 | 1983 | 9 | 0.000 |
Why?
|
Mice, Nude | 1 | 1983 | 258 | 0.000 |
Why?
|
Intraoperative Care | 1 | 1983 | 36 | 0.000 |
Why?
|
Anesthesia | 1 | 1983 | 48 | 0.000 |
Why?
|
Postoperative Care | 1 | 1983 | 114 | 0.000 |
Why?
|
Emergencies | 1 | 1983 | 111 | 0.000 |
Why?
|
Risk | 1 | 1983 | 364 | 0.000 |
Why?
|
Preoperative Care | 1 | 1983 | 180 | 0.000 |
Why?
|